Swedish CELLINK AB (publ) ("CELLINK") has entered into an agreement with the shareholders of German Nanoscribe Holding GmbH ("Nanoscribe") on the acquisition of all outstanding shares in the company for a purchase price on a cash- and debt-free basis of approximately EUR 34 million as fixed purchase price and approximately EUR 16 million in earn-outs. Nanoscribe is a market leading and award-winning company focusing on development of high-precision 3D printers based on Two-Photon Polymerization technology. Approximately 35% of the fixed purchase price of EUR 34 million will be paid in newly issued shares of series B in CELLINK, the remaining portion will be paid cash.
Hengeler Mueller advised CELLINK on the transaction. The team was led bei partners Hans-Jörg Ziegenhain and Elisabeth Kreuzer (both Corporate/M&A) and included partners Markus Ernst (Tax) (all Munich), Dirk Uwer (Public Law, Düsseldorf) and Hendrik Bockenheimer (Employment, Frankfurt), counsel Jakub Lorys (Corporate/M&A, Munich), Susanne Koch (Public Law) and Patrick Wilkening (IP/IT) (both Düsseldorf) as well as associates Johannes Schmidt, Ioanna Tsotsa (both Corporate/M&A), Verena Klosterkemper (Tax) (all Munich), Patrick Schmidt (IP/IT) and Selina Rohr (Employment) (both Frankfurt).